CLB

14.85

5.39% 0.76

Handel nachbörslich: 14.85

Core Laboratories Inc (CLB)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$14.09

Offen:

$14.16

24-Stunden-Volumen:

399.21K

Relative Volume:

1.31

Marktkapitalisierung:

$695.38M

Einnahmen:

$502.79M

Nettoeinkommen (Verlust:

$23.71M

KGV:

29.70

EPS:

0.5

Netto-Cashflow:

$6.35M

1W Leistung:

+1.50%

1M Leistung:

-10.43%

6M Leistung:

-16.05%

1J Leistung:

-7.01%

1-Tages-Spanne:

$14.12

$15.00

1-Wochen-Bereich:

$12.95

$15.00

52-Wochen-Spanne:

$12.95

$25.13

Core Laboratories Inc Stock (CLB) Company Profile

Firmenname

Core Laboratories Inc

Sektor

Energy (252)

Branche

Oil & Gas Equipment & Services (70)

Telefon

713-328-2673

Adresse

6316 WINDFERN ROAD, HOUSTON

Mitarbeiter

3,500

Twitter

@corelabcompany

Nächster Verdiensttermin

2025-01-29

Neueste SEC-Einreichungen

CLB's Discussions on Twitter

Vergleichen Sie CLB mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CLB Core Laboratories Inc	14.85	695.38M	502.79M	23.71M	6.35M	0.50
SLB Schlumberger Ltd	41.37	58.74B	36.29B	4.46B	4.47B	3.11
BKR Baker Hughes Company	42.89	42.47B	27.83B	2.98B	2.05B	2.98
HAL Halliburton Co	25.00	21.70B	22.94B	2.50B	2.42B	2.83
TS Tenaris S A Adr	37.23	21.34B	13.09B	2.65B	2.52B	4.5936
FTI Technipfmc Plc	26.67	11.22B	8.79B	671.20M	856.30M	1.52

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-06-30	Herabstufung	Citigroup	Neutral → Sell
2023-04-18	Herabstufung	BofA Securities	Neutral → Underperform
2023-01-09	Hochstufung	BofA Securities	Underperform → Neutral
2022-10-07	Hochstufung	Citigroup	Sell → Neutral
2022-09-26	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2022-04-18	Herabstufung	Piper Sandler	Neutral → Underweight
2021-10-18	Herabstufung	BofA Securities	Neutral → Underperform
2021-07-09	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-06-14	Herabstufung	Citigroup	Neutral → Sell
2020-12-18	Herabstufung	JP Morgan	Neutral → Underweight
2020-11-11	Bestätigt	Cowen	Market Perform
2020-10-13	Hochstufung	BofA Securities	Underperform → Neutral
2020-09-29	Hochstufung	ABN Amro	Sell → Hold
2020-07-16	Herabstufung	Scotiabank	Sector Outperform → Sector Perform
2020-04-13	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2020-03-09	Herabstufung	BofA/Merrill	Buy → Underperform
2020-03-09	Herabstufung	Evercore ISI	Outperform → In-line
2020-01-31	Bestätigt	Cowen	Market Perform
2020-01-30	Fortgesetzt	Johnson Rice	Buy
2020-01-14	Eingeleitet	Bernstein	Mkt Perform
2020-01-02	Herabstufung	Stifel	Buy → Hold
2019-12-31	Bestätigt	Cowen	Market Perform
2019-07-10	Hochstufung	BofA/Merrill	Neutral → Buy
2019-02-25	Hochstufung	Tudor Pickering	Hold → Buy
2018-12-19	Herabstufung	Credit Suisse	Outperform → Neutral
2018-12-11	Herabstufung	JP Morgan	Overweight → Neutral
2018-11-16	Hochstufung	Guggenheim	Neutral → Buy
2018-11-01	Hochstufung	ABN Amro	Sell → Buy
2018-10-29	Bestätigt	Cowen	Market Perform

Alle ansehen

Core Laboratories Inc Aktie (CLB) Neueste Nachrichten

06:42 AM

Core Laboratories (NYSE:CLB) Hits New 52-Week LowHere's What Happened - MarketBeat

06:42 AM

Mar 08, 2025

Fisher Asset Management LLC Has $16.29 Million Stock Position in Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Mar 08, 2025

Mar 06, 2025

Core Laboratories (NYSE:CLB) Shares Down 4.9%Here's Why - MarketBeat

Mar 06, 2025

Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating - Marketscreener.com

Mar 06, 2025

The three-year underlying earnings growth at Core Laboratories (NYSE:CLB) is promising, but the shareholders are still in the red over that time - Simply Wall St

Mar 06, 2025

Mar 05, 2025

Principal Financial Group Inc. Grows Position in Core Laboratories Inc. (NYSE:CLB) - Defense World

Mar 05, 2025

Mar 04, 2025

Rhumbline Advisers Decreases Stake in Core Laboratories Inc. (NYSE:CLB) - Defense World

Mar 04, 2025

Mar 03, 2025

Is Core Stock Worth Buying After a 27% Surge in 6 Months? - Yahoo Finance

Mar 03, 2025

Feb 28, 2025

Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report? - Yahoo Finance

Feb 28, 2025

Feb 27, 2025

Dividend Coverage: This Energy Services Company has a Dividend Yield of 2.32%; Will Trade Ex-Dividend on October 19, 2017 - ACCESS Newswire

Feb 27, 2025

Core Laboratories stock hits 52-week low at $14.61 - Investing.com

Feb 27, 2025

Feb 24, 2025

Citigroup Forecasts Strong Price Appreciation for Core Laboratories (NYSE:CLB) Stock - MarketBeat

Feb 24, 2025

Feb 23, 2025

Kornitzer Capital Management Inc. KS Purchases Shares of 35,515 Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Feb 23, 2025

Feb 21, 2025

Van ECK Associates Corp Acquires 26,237 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Feb 21, 2025

Feb 20, 2025

The past five years for Core Laboratories (NYSE:CLB) investors has not been profitable - Yahoo Finance

Feb 20, 2025

Feb 19, 2025

Rice Hall James & Associates LLC Buys New Shares in Core Laboratories Inc. (NYSE:CLB) - MarketBeat

Feb 19, 2025

Feb 18, 2025

Van ECK Associates Corp Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World

Feb 18, 2025

Feb 13, 2025

Core Laboratories Inc. /DE/ SEC 10-K Report - TradingView

Feb 13, 2025

Feb 08, 2025

Core Laboratories Inc. (NYSE:CLB) Stock Holdings Lifted by Boston Trust Walden Corp - MarketBeat

Feb 08, 2025

Feb 07, 2025